Emergent BioSolutions, already flush with products against public health threats like anthrax attacks and opioid overdoses, is expanding its arsenal…
Super UserSeptember 26, 2022
Fifth Milestone Achieved by HemoShear with Novel Compounds for Second Target CHARLOTTESVILLE, Va., Sept. 21, 2022 /PRNewswire/ -- HemoShear Therapeutics, Inc., a…
Super UserSeptember 26, 2022
Doubling the University of Maryland BioPark's lab space, the two-phase 4MLK development project will represent more than $320 million in…
Super UserSeptember 26, 2022
ROCKVILLE, Md., Sept. 21, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on…
Super UserSeptember 22, 2022
The U.S. bioeconomy is booming. Valued at nearly one trillion dollars and predicted to grow globally to over $30 trillion…
Super UserSeptember 21, 2022
OAKLAND, Calif. - President Biden revived his call for a nationwide cancer moonshot effort on Monday, as he marked the…
Super UserSeptember 21, 2022
Startup companies have traditionally looked for the most experienced venture capitalists they could find to get their businesses off the…
Super UserSeptember 16, 2022
One of Maryland’s premiere medical networks just announced an eight-figure investment into the economic development of local and marginalized communities…
Super UserSeptember 16, 2022
CHARLOTTESVILLE, Va., Sept. 15, 2022 /PRNewswire/ -- AMPEL BioSolutions today announced a breakthrough in precision and personalized medicine that can detect and predict the…
Super UserSeptember 16, 2022